HK1035001A1 - Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters - Google Patents
Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid estersInfo
- Publication number
- HK1035001A1 HK1035001A1 HK01105718A HK01105718A HK1035001A1 HK 1035001 A1 HK1035001 A1 HK 1035001A1 HK 01105718 A HK01105718 A HK 01105718A HK 01105718 A HK01105718 A HK 01105718A HK 1035001 A1 HK1035001 A1 HK 1035001A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tetrahydro
- pyridine
- hydroxy
- methyl
- separation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/816—Enzyme separation or purification by solubility
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19809649A DE19809649A1 (de) | 1998-03-06 | 1998-03-06 | Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester |
PCT/EP1999/001113 WO1999045133A1 (de) | 1998-03-06 | 1999-02-20 | Verfarhen zur enzymatischen enantiomeren-trennung von 3(r)- und 3(s)-hydroxy-1- methyl-4-(2,4, 6-trimethoxyphenyl)-1, 2,3,6- tetrahydro-pyridin bzw. der carbonsäureester |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1035001A1 true HK1035001A1 (en) | 2001-11-09 |
Family
ID=7859957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01105718A HK1035001A1 (en) | 1998-03-06 | 2001-08-15 | Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters |
Country Status (23)
Country | Link |
---|---|
US (1) | US6406912B1 (ru) |
EP (1) | EP1071807B1 (ru) |
JP (1) | JP4344089B2 (ru) |
KR (1) | KR100779864B1 (ru) |
CN (1) | CN1230554C (ru) |
AR (1) | AR018574A1 (ru) |
AT (1) | ATE474061T1 (ru) |
AU (1) | AU758106B2 (ru) |
BR (2) | BR9908557A (ru) |
CA (1) | CA2322842C (ru) |
CY (1) | CY1110919T1 (ru) |
CZ (1) | CZ301944B6 (ru) |
DE (2) | DE19809649A1 (ru) |
DK (1) | DK1071807T3 (ru) |
ES (1) | ES2348394T3 (ru) |
HK (1) | HK1035001A1 (ru) |
HU (1) | HU227994B1 (ru) |
ID (1) | ID27000A (ru) |
PL (1) | PL195006B1 (ru) |
PT (1) | PT1071807E (ru) |
RU (1) | RU2241040C2 (ru) |
TR (1) | TR200002576T2 (ru) |
WO (1) | WO1999045133A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2372180A1 (en) | 1999-05-13 | 2000-11-23 | Shell Internationale Research Maatschappij B.V. | Hydrocarbon conversion process |
DE60235374D1 (de) | 2001-05-15 | 2010-04-01 | Novartis Ag | Verfahren zur herstellung von substituierten carbonsäureestern mittels enzymatischer hydrolyse |
CN104278061A (zh) * | 2014-10-01 | 2015-01-14 | 青岛科技大学 | 一种生产氟苯基甲基丙酸甲酯的产朊酵母还原法 |
CN104232700A (zh) * | 2014-10-01 | 2014-12-24 | 青岛科技大学 | 一种生物法生产(2r,3s)羟基丙酸甲酯的方法 |
MX2017013383A (es) | 2015-04-20 | 2017-12-07 | Tolero Pharmaceuticals Inc | Prediccion de respuesta a alvocidib mediante perfilado mitocondrial. |
TR201911032T4 (tr) | 2015-05-18 | 2019-08-21 | Tolero Pharmaceuticals Inc | Artırılmış biyoyararlanıma sahip alvocıdıb ön ilaçları. |
AU2016301315C1 (en) | 2015-08-03 | 2022-07-07 | Sumitomo Pharma Oncology, Inc. | Combination therapies for treatment of cancer |
WO2018094275A1 (en) | 2016-11-18 | 2018-05-24 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
KR20190099260A (ko) | 2016-12-19 | 2019-08-26 | 톨레로 파마수티컬스, 인크. | 프로파일링 펩티드 및 감도 프로파일링을 위한 방법 |
WO2019055579A1 (en) | 2017-09-12 | 2019-03-21 | Tolero Pharmaceuticals, Inc. | TREATMENT REGIME FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 ALVOCIDIB INHIBITOR |
WO2020117988A1 (en) | 2018-12-04 | 2020-06-11 | Tolero Pharmaceuticals, Inc. | Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer |
US11793802B2 (en) | 2019-03-20 | 2023-10-24 | Sumitomo Pharma Oncology, Inc. | Treatment of acute myeloid leukemia (AML) with venetoclax failure |
CN110577974B (zh) * | 2019-09-10 | 2021-07-20 | 杭州澳赛诺生物科技有限公司 | 手性3-羟基-1,2,3,6-四氢吡啶的合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2691986B2 (ja) | 1987-08-28 | 1997-12-17 | チッソ株式会社 | ピリジン骨格を有する光学活性化合物の製造法 |
DE3743824C2 (de) * | 1987-12-23 | 1997-03-06 | Hoechst Ag | Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung |
JPH0641075A (ja) * | 1990-09-01 | 1994-02-15 | Kazuo Achinami | 新規な1,4−ジヒドロピリジン化合物及びその製造方法 |
AU647603B2 (en) * | 1991-04-02 | 1994-03-24 | Hoechst Aktiengesellschaft | An immobilized biocatalyst, its preparation and use for ester synthesis in a column reactor |
JPH0690790A (ja) * | 1992-09-08 | 1994-04-05 | Mercian Corp | 光学活性1,4−ジヒドロピリジン−3,5−ジカルボン酸・モノエステル誘導体の製造方法 |
DE19802449A1 (de) * | 1998-01-23 | 1999-07-29 | Hoechst Marion Roussel De Gmbh | Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin |
-
1998
- 1998-03-06 DE DE19809649A patent/DE19809649A1/de not_active Withdrawn
-
1999
- 1999-02-20 AT AT99910248T patent/ATE474061T1/de active
- 1999-02-20 EP EP99910248A patent/EP1071807B1/de not_active Expired - Lifetime
- 1999-02-20 ES ES99910248T patent/ES2348394T3/es not_active Expired - Lifetime
- 1999-02-20 BR BR9908557-7A patent/BR9908557A/pt not_active IP Right Cessation
- 1999-02-20 CA CA2322842A patent/CA2322842C/en not_active Expired - Lifetime
- 1999-02-20 WO PCT/EP1999/001113 patent/WO1999045133A1/de active IP Right Grant
- 1999-02-20 CN CNB998035955A patent/CN1230554C/zh not_active Expired - Lifetime
- 1999-02-20 PT PT99910248T patent/PT1071807E/pt unknown
- 1999-02-20 RU RU2000125273/13A patent/RU2241040C2/ru active
- 1999-02-20 TR TR2000/02576T patent/TR200002576T2/xx unknown
- 1999-02-20 KR KR1020007009843A patent/KR100779864B1/ko not_active IP Right Cessation
- 1999-02-20 CZ CZ20003223A patent/CZ301944B6/cs not_active IP Right Cessation
- 1999-02-20 DK DK99910248.6T patent/DK1071807T3/da active
- 1999-02-20 HU HU0101795A patent/HU227994B1/hu unknown
- 1999-02-20 JP JP2000534664A patent/JP4344089B2/ja not_active Expired - Lifetime
- 1999-02-20 BR BRPI9908557A patent/BRPI9908557B8/pt unknown
- 1999-02-20 AU AU29275/99A patent/AU758106B2/en not_active Expired
- 1999-02-20 ID IDW20001691A patent/ID27000A/id unknown
- 1999-02-20 PL PL342877A patent/PL195006B1/pl unknown
- 1999-02-20 DE DE59915183T patent/DE59915183D1/de not_active Expired - Lifetime
- 1999-02-20 US US09/623,563 patent/US6406912B1/en not_active Expired - Lifetime
- 1999-03-04 AR ARP990100907A patent/AR018574A1/es active IP Right Grant
-
2001
- 2001-08-15 HK HK01105718A patent/HK1035001A1/xx not_active IP Right Cessation
-
2010
- 2010-09-22 CY CY20101100850T patent/CY1110919T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU757941C (en) | Method for producing metallurgical coke | |
PL341294A1 (en) | Method of synthesising 1,3-dioles | |
HK1049731B (zh) | 記錄方法 | |
AU5311296A (en) | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists | |
HK1035001A1 (en) | Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters | |
IL173393A0 (en) | 4-carboxyamino-2- substituted-1,2,3,4- tetrahydroquinolines as cetp inhibitors | |
SI1114033T1 (en) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors | |
AU1831597A (en) | Methods and compositions for inhibiting hexokinase | |
AU2226299A (en) | Method of inventorying liquor | |
EP1143953A3 (en) | Method of inhibiting angiogenesis | |
PL330753A1 (en) | Method of obtaining 2,3-dihalogenopropanols | |
SG102603A1 (en) | Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline | |
ZA971735B (en) | Novel esters of 1,4-disubstituted piperidine derivatives | |
PL313204A1 (en) | Derivatives of piperidine, method of obtaining them | |
PL344390A1 (en) | Method of obtaining derivatives of 1,4-dihydropyridine | |
ZA96702B (en) | 4-(1H-indol-1-yl)-1-piperidinyl derivatives. | |
HK1030981A1 (en) | Timing block or disc and method for its production | |
AU5101798A (en) | Method for oral administration of buspirone | |
AU1788800A (en) | Derivative of paroxetine | |
HUP0002709A3 (en) | Process for the reduction of 1-substituted -3-hydroxymethyl-4- (4-fluorophenyl)tetrahydropyridines | |
AU5655698A (en) | Suspension crystallization method | |
GR3033316T3 (en) | Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders | |
AU2219697A (en) | Compositions and methods for inhibiting clot formation | |
ZA97329B (en) | Piperidine or tetrahydropyridine derivatives | |
AU5655798A (en) | Suspension crystallization method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20190219 |